Background: Sevoflurane and desflurane are widely used in balanced anaesthesia in combination with opioid analgesics. The opioid remifentanil is frequently chosen because of its extremely rapid pharmacokinetics. However, intraoperative high-dose remifentanil is associated with increased postoperative pain and rescue analgesic use owing to acute tolerance and opioid-induced hyperalgesia. This study aimed to compare intraoperative remifentanil requirements during equiminimum alveolar concentration (MAC) sevoflurane and desflurane anaesthesia via surgical pleth index-guided remifentanil administration. Methods: Eighty-two subjects undergoing laparoscopic cholecystectomy were randomly allocated to two groups receiving either sevoflurane (n¼40) or desflurane (n¼42). Anaesthesia was maintained with the assigned inhaled anaesthetics and remifentanil. End-tidal anaesthetic concentration was maintained at age-corrected 1.0 MAC, and remifentanil infusion was continuously adjusted to achieve a surgical pleth index of 20e50. Mean remifentanil infusion rate, which was the primary outcome of the study, was calculated as the total infused remifentanil dose per kg body weight per minute of total operative time. Results: Mean remifentanil infusion rate [mean (standard deviation)] was significantly higher in the sevoflurane group
Editor's key points
Volatile anaesthetics are commonly administered in combination with remifentanil infusions. As with most opioids, high doses of remifentanil are undesirable as they are associated with tolerance and hyperalgesia. At equipotent doses for immobility, different volatile anaesthetics may cause different degrees of antinociception. Desflurane appears to have greater antinociceptive properties than sevoflurane, and to be associated with lower remifentanil dose requirements.
The inhaled anaesthetics sevoflurane and desflurane have recently been widely used in balanced anaesthesia because of their rapid pharmacokinetic properties, in combination with anaesthetic supplements, such as opioid analgesics. 1e3 The opioid remifentanil is frequently chosen owing to its rapid onset, short duration of action, and quick recovery time. 4, 5 However, intraoperative high-dose remifentanil is associated with increased postoperative pain and rescue analgesic use owing to acute tolerance and opioid-induced hyperalgesia.
6e9
Accurate intraoperative nociceptioneantinociception balance assessment might potentially improve opioid analgesic titration, thereby reducing opioid-related side effects. 10, 11 This previously depended on conventional empirical assessments, such as changes in heart rate or blood pressure; however, the surgical pleth index (SPI) was recently proposed as a monitoring tool for nociceptioneantinociception balance during general anaesthesia.
12e15
General anaesthesia results from a combination of hypnosis, antinociception, and immobility. 16e18 Therefore, ideal balanced anaesthesia is achieved using an optimal combination of various anaesthetics with different mechanisms of action. 3 The dose of inhaled anaesthetics has conventionally been measured in minimum alveolar concentration (MAC) multiples. 19 However, as the endpoint of the MAC is immobility, it is a reflection of the activity of inhaled anaesthetics on the spinal cord (a-motor neuron depression) rather than the cerebrum (hypnosis and antinociception). 20e22 Therefore, it is unclear whether equi-MAC doses of different inhaled anaesthetics ensure equivalent hypnotic or antinociception levels. 23 The authors hypothesised that sevoflurane and desflurane at equi-MAC would not show a similar opioid consumption during SPI-guided analgesic administration. This study aimed to compare intraoperative remifentanil requirements during 1.0 MAC sevoflurane and desflurane anaesthesia in patients undergoing laparoscopic cholecystectomy under SPI-guided remifentanil administration.
Methods

Study design and subjects
This prospective randomised study was approved by the Institutional Review Board at Kangbuk Samsung Hospital, Seoul, Korea (approval no: KBSMC2016-05-058), was internationally registered at clinicaltrials.gov (identifier: NCT02830243; principal investigator: K.-H.R.; registration date: July 9, 2016), and conformed to the tenets of the Declaration of Helsinki. Written informed consent was obtained from 90 patients aged 19e65 yr with ASA physical status classification 1e2, scheduled for elective laparoscopic cholecystectomy.
The preoperative exclusion criteria were as follows: history of administration of any medication affecting the autonomic or central nervous system (e.g. anticholinergics, b-blockers, antidepressants, anxiolytics, hypnotics, or analgesics); presence of any psychiatric or neurological disease (e.g. major depressive disorder, dementia, or stroke), cardiac dysrhythmia, or diabetes mellitus; and history of drug or alcohol abuse. Patients found to require conversion to laparotomy or incidental lower abdominal procedures owing to adhesion or injury were excluded from the final analysis.
The eligible patients were randomly assigned into two equal groups (sevoflurane and desflurane groups) using a random-permuted block randomisation algorithm via a webbased response system (www.randomization.com). Blinding was performed using consecutively numbered opaque envelopes, each containing a folded paper stating the anaesthetic group, stored and opened by an independent researcher in a laboratory distant from the hospital. The group assignment was not changed after the envelope was opened.
Anaesthetic monitoring
The subjects did not receive any premedication. After arrival in the operating theatre, standard monitoring (S/5™ Anaesthesia Monitor; GE Healthcare, Helsinki, Finland), including three-lead electrocardiography, non-invasive blood pressure assessment, and pulse oximetry, was performed. A disposable BIS-Quatro™ sensor (Covidien, Mansfield, MA, USA) and an Entropy EasyFit™ sensor (GE Healthcare) were attached side by side to the forehead as recommended by the manufacturers. The bispectral index (BIS) and entropy values were monitored to measure the hypnotic level of the general anaesthesia.
The SPI was used as a surrogate measure for intraoperative nociceptioneantinociception balance. A pulse oximeter sensor was attached to the contralateral index finger to the arm with a non-invasive blood pressure cuff, from which photoplethysmographic waveforms were collected for SPI computation (S/5™ Anaesthesia Monitor; GE Healthcare). The SPI is a dimensionless numerical index acquired from the photoplethysmographic probe used for monitoring peripheral oxygen saturation. It is determined by a combination of the central sympathetic tone represented by the heartbeat interval (HBI) and the peripheral sympathetic tone represented by the photoplethysmographic pulse wave amplitude (PPGA). The SPI is computed using an algorithm that combines normalised HBI (HBI norm ) and normalised PPGA (PPGA norm ) using the following equation:
The SPI ranges from 0 to 100, representing minimum and maximum surgical stress levels, respectively. The optimal SPI during surgery has not been studied; however, an SPI of 50 is claimed to indicate a mean level of surgical analgesia. 12 The degree of muscle relaxation was measured by the train-of-four count (TOFc) using a piezoelectric neuromuscular monitoring device (M-NMT MechanoSensor™; GE Healthcare). Moderate neuromuscular block (TOFc of 1e2) was maintained throughout the operative time in both groups. The end-tidal anaesthetic gas concentration was continuously measured using an infrared spectrophotometric analyser (S/ 5™ Anaesthesia Monitor; GE Healthcare). The end-tidal partial pressure of carbon dioxide and nasopharyngeal temperature were measured to ensure normocapnia and normothermia, respectively.
Study protocol
Before induction of anaesthesia, the baseline values (pre-induction data) for the SPI, BIS, response entropy (RE), state entropy (SE), mean arterial pressure (MAP), and heart rate (HR) were recorded. In both groups, general anaesthesia was induced using propofol (Fresofol® MCT 1%; Fresenius Kabi Austria GmbH, Graz, Austria) via a target-controlled infusion (TCI) pump (Orchestra Base Primea®; Fresenius Vial, Brezins, France). The initial target effect-site concentration of propofol (Ce prop ) was set to 3.0 mg ml À1 using the Marsh pharmacokinetic model, 24 and propofol infusion was started in the flash mode, the fastest infusion setting for reaching the target concentration. To minimise the propofol dose, immediately after loss of consciousness, the Ce prop in the TCI pump was adjusted to 0.0 mg ml À1 ; propofol infusion was stopped; and the total infused dose was recorded. Simultaneously, approximately 2.0 MAC of either sevoflurane (Sevorane®; AbbVie Ltd, Maidenhead, UK) or desflurane (Suprane®; Baxter Healthcare, Guayama, Puerto Rico) was administered via a tight-fitting facemask. After 0.8 mg kg À1 rocuronium was administered, orotracheal intubation was performed. To compare the remifentanil requirements only for surgical stimulation, anaesthesia was induced without opioids. The inhaled anaesthetic gas concentration increase was facilitated by over-pressurisation, with the goal of reaching 1.0 MAC. The corrected MAC was used on the basis of an agerelated iso-MAC chart. 25, 26 The anaesthetic vaporiser was adjusted by an independent anaesthesiologist, who was blinded to the study protocol, to maintain constant end-tidal anaesthetic gas concentrations at 1.0 MAC throughout the study period. To ensure brain-alveolar equilibration of the inhaled anaesthetics and allow the effects of propofol to dissipate, surgery was commenced after an initial 30-min waiting period from the induction of anaesthesia. After confirming a brain-alveolar equilibration condition in which a constant end-tidal anaesthetic concentration at 1.0 MAC was maintained without vaporiser adjustment for the last 10 min of the waiting period, the SPI, BIS, RE, SE, MAP, and HR (preincision data) were recorded, and the skin was then incised. Anaesthesia was maintained with the randomly assigned inhaled anaesthetic at 1.0 MAC, in combination with remifentanil (Ultiva™; GlaxoSmithKline, Verona, Italy). Remifentanil continuous infusion was adjusted on the basis of the SPI using the TCI pump in an identical manner in both groups. To minimise dead space in the intravenous line, the remifentanil infusion line was connected closely to the patients using a three-way stopcock directly attached to the intravenous cannula. One minute before skin incision, the remifentanil infusion was started in the flash mode, and the time was recorded. The target effect-site concentration of remifentanil (Ce remi ) was initially set at 3.0 ng ml À1 using the Minto pharmacokinetic model. 27 Subsequently, remifentanil infusion was continuously adjusted throughout the study period to achieve an SPI range between 20 and 50 by an independent researcher who was blinded to the group allocation. The Ce remi was adjusted by step of 0.5 ng ml À1 every 1 min to maintain the target SPI range. If the SPI remained within the target range, the Ce remi was not adjusted. All laparoscopic procedures were performed by one experienced surgeon using standard techniques.
Outcome measures
Data were collected at the following three pre-defined time points:
1. Pre-induction data: baseline values before induction of anaesthesia. 2. Pre-incision data: values before skin incision under 1.0 MAC inhaled anaesthesia. 3. Intraoperative data: values at the dissection of the gallbladder away from the liver bed under SPI-guided remifentanil administration.
The measurement window at each time point was designated as 1 min, and data were recorded at 30 s intervals. Therefore, the mean values of two measurements of all monitoring data, including the SPI, BIS, RE, SE, MAP, and HR, for 1 min were used. Data were recorded manually by an independent researcher who was blinded to the group allocation.
During the main surgical procedure (i.e. dissection of the gallbladder away from the liver bed), the Ce remi was recorded at steady-state analgesia (defined as a condition in which an SPI of 20e50 is maintained without infusion pump adjustment for >10 min), along with hypnotic (i.e. BIS, RE, and SE) and haemodynamic parameters (MAP and HR). At the end of surgery, the remifentanil infusion was discontinued, and the time and total administered remifentanil dose (mg) were recorded. The operative time (i.e. remifentanil infusion time) was defined as the time from skin incision to removal of the laparoscopic ports. The mean remifentanil infusion rate, which was the primary outcome of the study, was calculated as the total remifentanil dose per kg body weight, per minute of the operative time.
To ensure brain-alveolar equilibration of the inhaled anaesthetics, all study outcomes were collected only at an equilibrium condition in which a constant end-tidal anaesthetic concentration of age-corrected 1.0 MAC was maintained without vaporiser dial adjustment for >10 min. To minimise the impact of propofol on anaesthesia depth, the outcomes were obtained after the Ce prop decreased below 0.1 mg ml À1 . Intraoperative awareness was assessed within 72 hours after operation using Brice's structured interview. 28 At any time during the operative time, if the BIS or SE was >70, MAP was <60 mmHg, or HR was <45 or >140 beats min
À1
, then additional hypnotics, vasopressors, anticholinergics, or b-blockers were administered, respectively; the subjects were considered a dropout; and the data for such subjects were excluded from the final analysis.
Statistical analysis
The primary outcome in this study was the mean remifentanil infusion rate 
Results
Between July 2016 and October 2016, 135 patients were assessed for eligibility; among them, one declined participation, and 44 were ineligible according to the exclusion criteria. Therefore, 90 subjects were randomised to two equal groups. Eight subjects dropped out owing to conversion to laparotomy, severe subcutaneous emphysema, and administration of atropine, ephedrine, and esmolol. Therefore, the final analyses were confined to 82 subjects, with 40 subjects in the sevoflurane group and 42 subjects in the desflurane group (Fig. 1) . Patient characteristics were comparable between both groups ( Table 1) . The baseline SPI, BIS, entropy values, and haemodynamic parameters before induction of anaesthesia, propofol and rocuronium doses, and operative time were not significantly different between the two groups ( Table 2) . No anaesthesia awareness was reported.
During SPI-guided anaesthesia, there were significant inter-group differences in the remifentanil requirements for observed in the pre-incision entropy values. Regarding the preincision haemodynamics, the MAP was significantly higher in the sevoflurane group than in the desflurane group, whereas the HR showed no significant difference between the groups. Table 4 presents data at steady-state analgesia during the main surgical procedure under 1.0 MAC inhaled anaesthesia. The intraoperative BIS was significantly higher in the sevoflurane group than in the desflurane group [47 (7) vs. 36 (8) 
Discussion
The objective of this randomised controlled trial was to compare the remifentanil requirements to maintain an equal SPI during equi-MAC sevoflurane and desflurane anaesthesia. The two inhaled anaesthetics at 1.0 MAC did not show a similar intraoperative remifentanil consumption under SPIguided analgesic administration. The rapid pharmacokinetics of sevoflurane and desflurane allowed the widespread clinical use of balanced anaesthesia in combination with short-acting opioid analgesics, such as remifentanil.
1e5 However, over-administered opioid analgesics during surgery delay recovery from anaesthesia and cause opioid-related side effects. In particular, excessive intraoperative administration of remifentanil leads to opioidinduced hyperalgesia and acute opioid tolerance, resulting in increased postoperative pain and rescue analgesic use. 6e9 If intraoperative nociceptioneantinociception balance is accurately assessed, it might potentially improve titration of opioid analgesics and reduce opioid-related side effects. 10, 11 However, the tools that have traditionally been used in these assessments, including the numerical rating scale and visual analogue scale, are not applicable during general anaesthesia and are not objective assessments. In recent decades, there have been considerable efforts to determine intraoperative antinociception levels. Several methods have been proposed to assess intraoperative nociceptioneantinociception balance: cutaneous vascular sympathetic response (skin conductance variations), pupillary dilatation reflex (infrared pupillometry), cardiac parasympathetic response (analgesia nociception index), and cardiac and vascular sympathetic responses (SPI). 16e18 Although the SPI has been the most widely studied parameter, 10e15 there is no well-validated gold standard monitoring tool for nociceptioneantinociception balance during general anaesthesia to date. 16 In this study, remifentanil consumption under SPI-guided administration was significantly lower in the desflurane group than in the sevoflurane group during equi-MAC anaesthesia. The reason for this difference is unclear; however, there are some potential explanations. First, it may have been because of the different effects of the two inhaled anaesthetics on the vascular tone. Sevoflurane and desflurane have a direct activity on the peripheral vascular tissues, and both are systemic vasodilators through endothelium-mediated vascular relaxation. 1, 2 If desflurane has more potent vasodilative properties than sevoflurane, the opioid requirements to maintain an equal SPI would be reduced during desflurane anaesthesia because the SPI is heavily influenced by the PPGA, which denotes the peripheral vascular tone. 12 This hypothesis is supported by the fact that the MAP before skin incision was lower in the desflurane group than in the sevoflurane group (Table 3) . Second, this difference might have been a result of the different anaesthetic effects between the two inhaled anaesthetics. We have previously reported that sevoflurane and desflurane did not produce similar SPI and BIS under a standardised tetanic stimulation during a steady state of 1.0 MAC single-agent inhaled anaesthesia, 23 consistent with the pre-incision data of the current study. These results suggest that the inhaled anaesthetic equivalence of the effects on the spinal cord might not be equivalent to that on the cerebrum. If the two inhaled anaesthetics do not have equivalent anaesthetic properties at equi-MAC, the opioid requirements to maintain an equal SPI would not be similar. These findings suggest that the equi-MAC dose of the two anaesthetics might not ensure an equivalent depth of anaesthesia. Third, this difference might be explained on the basis of the differential impact of the two anaesthetics on autonomic balance because the SPI is a surrogate measure of the sympathetic response to nociceptive stimulation. 12 Inhaled anaesthetics with more potent sympatholytic effects would reduce the opioid requirements to maintain an equal SPI. Based on this premise and the result of the study, it is inferred that desflurane might have a more potent sympatholytic effect than sevoflurane. However, this interpretation is contradicted by most previous literature, which reported that desflurane was associated with sympathetic stimulation. 1,2 Because this b-adrenergic activation of desflurane is related to the rapidity of the increase in concentration rather than to the absolute concentration, 29, 30 more research is necessary to understand the impact of inhaled anaesthetics on the sympathetic nervous system better.
In the present study, we measured EEG-derived indices and haemodynamic parameters simultaneously in addition to the SPI. Regarding the EEG measures, the equi-MAC of the two inhaled anaesthetics did not produce similar BIS and entropy values. This result is consistent with the results of previous studies, 23, 31 which suggest that the effect of the two anaesthetics on the EEG at equi-MAC may be different. Regarding the haemodynamic measures, both groups showed stable haemodynamics during the surgery, with the MAP and HR maintained within ±20% of the pre-induction baseline values. However, the equi-MAC of the two anaesthetics did not yield similar haemodynamic profiles. Previous studies have shown a similar effect of opioids on the MAC reduction of different inhaled anaesthetics, 32e34 where the fentanyl doses to produce a 50% MAC reduction of desflurane, isoflurane, and sevoflurane were similar; however, the current haemodynamic data suggest that this is not applicable for haemodynamics if the haemodynamic profile is different. During the main surgical procedure, sevoflurane resulted in a lower HR compared with desflurane, whereas there was no significant difference in the MAP. This difference in the HR might have been the result of desflurane-induced sympathetic stimulation, as sevoflurane results in a relatively stable HR, whereas desflurane increases HR because of sympathetic nervous system activation.
1,2 Another explanation is opioidinduced bradycardia: opioids have a vagally mediated negative chronotropic effect. 5, 35 Here, remifentanil consumption was significantly higher in the sevoflurane group than in the desflurane group, which might have led to relative bradycardia in the former. Several limitations of this study should be noted. First, although the minimum propofol dose required for loss of consciousness was used, the sub-hypnotic propofol concentration might have influenced the SPI or BIS. If inhalation induction had been performed, these confounding factors would have been eliminated. However, this requires a rapid increase in desflurane concentration, potentially leading to significant tachycardia and hypertension. 29 It is also associated with a high incidence of laryngospasm and coughing owing to desflurane's respiratory irritant properties. 1,2 Therefore, anaesthetic induction using propofol was more appropriate. Second, this study may be criticised because the monitoring data were recorded manually. The fact that no automated recording system was used is the major limitation of this study. If an automated recording system had been used in the monitoring data collection, it would have provided more accurate information on serial changes in the variables over time to support our findings. Third, the results of this study should be interpreted with caution because the study is based on the premise that the SPI is a reliable monitoring index for nociceptioneantinociception balance. However, it is still a surrogate measure, and there is a lack of evidence for the recommended SPI cut-off values. 16 Therefore, the conclusion on whether different SPI profiles and analgesic requirements for the two inhaled anaesthetics at equi-MAC imply different antinociception properties should be drawn cautiously. This study emphasises the limitations of MAC as a measure of the dose of inhaled anaesthetics. In conclusion, during equi-MAC anaesthesia of 1.0 MAC, sevoflurane and desflurane did not show a similar intraoperative remifentanil consumption under SPI-guided opioid administration. However, it remains unclear whether this finding connotes different effects of the two inhaled anaesthetics on the depth of anaesthesia, vascular tone, or autonomic balance. To exclude the alternative interpretation of the result of the current study, further investigations that would use other monitors with different measuring mechanisms are warranted.
